Arbutus Biopharma Corporation (ABUS) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Arbutus Biopharma Corpora...

    NASDAQ: ABUS · Real-Time Price · USD
    4.09
    -0.11 (-2.62%)
    At close: Sep 08, 2025, 3:59 PM
    4.07
    -0.51%
    After-hours: Sep 08, 2025, 06:23 PM EDT

    Arbutus Biopharma Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 6.17M 18.14M 39.02M 10.99M
    Cost of Revenue
    		 1.38M 73.7M 1.43M 1.75M
    Gross Profit
    		 4.79M -55.56M 37.59M 9.23M
    Operating Income
    		 -76.32M -78.1M -65.46M -73.52M
    Interest Income
    		 6.58M 5.69M 2.19M 127K
    Pretax Income
    		 -69.92M -72.85M -65.01M -76.25M
    Net Income
    		 -69.92M -72.85M -69.46M -77.35M
    Selling & General & Admin
    		 22.11M 22.48M 17.83M 17.14M
    Research & Development
    		 54.04M 73.7M 84.41M 65.5M
    Other Expenses
    		 6.34M n/a 2.23M 1.87M
    Operating Expenses
    		 82.49M 96.24M 102.24M 82.64M
    Interest Expense
    		 137K 459K 1.73M 2.86M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 82.49M 96.24M 102.24M 82.64M
    Income Tax Expense
    		 n/a n/a 4.44M 1.1M
    Shares Outstanding (Basic)
    		 185.61M 165.96M 150.94M 106.24M
    Shares Outstanding (Diluted)
    		 185.61M 165.96M 150.94M 106.24M
    EPS (Basic)
    		 -0.38 -0.44 -0.46 -0.73
    EPS (Diluted)
    		 -0.38 -0.44 -0.46 -0.73
    EBITDA
    		 -68.4M -70.99M -61.86M -71.64M
    EBIT
    		 -69.78M -72.39M -63.29M -73.39M
    Depreciation & Amortization
    		 1.38M 1.4M 1.43M 1.75M

    Add to Watchlist